Investments
46Portfolio Exits
3Funds
1About Prometheus Capital
Prometheus Capital is a private equity fund with a focus on investments in China companies. The Firm invests mainly in start-up and growth-stage companies which have the potential to become leaders of their own sectors, excluding real estate, infrastructure, and mining sectors. Prometheus Capital is committed to providing professional support and assistance to all their investee companies to accelerate their growth and reach their new peaks. The Firm's focused sectors include but are not limited to energy conservation and environment protection, new material, clean-tech, medical devices and service, retail & consumer, modern agriculture, and high-end manufacturing.

Want to inform investors similar to Prometheus Capital about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Prometheus Capital News
Apr 14, 2023
SUMIDA-KU, JAPAN Tokyo, Japan, April 14, 2023 (GLOBE NEWSWIRE) -- Yoshitsu Co., Ltd (“Yoshitsu” or the “Company”) (Nasdaq: TKLF), a retailer and wholesaler of Japanese beauty and health products, as well as sundry products and other products in Japan, today announced that, on April 5, 2023, Prometheus Capital Fund I, L.P. (the “Fund”) became the beneficial owner of 2,063,300 ordinary shares of the Company, which represented approximately 5.7% of the Company’s issued and outstanding ordinary shares. Prometheus Capital GP Limited (“Prometheus Capital”) is the sole general partner of the Fund. Focused on early-to-growth-stage investment opportunities within the technology, media, and telecom and consumer sectors, Prometheus Capital manages four funds denominated in USD and RMB with total assets under management of $1 billion. Mr. Mei Kanayama, Principal Executive Officer of Yoshitsu, commented, “We are excited to have Prometheus Capital Fund I, L.P. as our new institutional shareholder. This investment by the prestigious Prometheus Capital is a recognition of our brand and our ability to create value for shareholders.” About Yoshitsu Co., Ltd Headquartered in Tokyo, Japan, Yoshitsu Co., Ltd is a retailer and wholesaler of Japanese beauty and health products, sundry products, and other products in Japan. The Company offers various beauty products (including cosmetics, skin care, fragrance, and body care products), health products (including over-the-counter drugs, nutritional supplements, and medical supplies and devices), sundry products (including home goods), and other products (including food and alcoholic beverages). The Company currently sells its products through directly-operated physical stores, through online stores, and to franchise stores and wholesale customers. For more information, please visit the Company’s website at https://www.ystbek.co.jp/irlibrary/ . Forward-Looking Statements All statements other than statements of historical fact in this press release are forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to,” or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. In addition, there is uncertainty about the further spread of the COVID-19 virus or the occurrence of another wave of cases and the impact it may have on the Company’s operations, the demand for the Company’s products, global supply chains, and economic activity in general. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and in its other filings with the U.S. Securities and Exchange Commission. For more information, please contact: Yoshitsu Co., Ltd
Prometheus Capital Investments
46 Investments
Prometheus Capital has made 46 investments. Their latest investment was in Yoshitsu as part of their PIPE on April 4, 2023.

Prometheus Capital Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
4/5/2023 | PIPE | Yoshitsu | Yes | 2 | ||
1/27/2022 | Private Equity | Poke Erchu | Yes | 1 | ||
11/23/2021 | Series C - III | Rescale | $50M | Yes | Fort Ross Ventures, Gaingels, Gopher Asset Management, Hitachi Ventures, Initialized Capital, Jeff Bezos, Keen Venture Partners, M12, Nautilus Venture Partners, NVIDIA, Paul Graham, Peter Thiel, Prometheus Capital, Republic Labs, Richard Branson, Sam Altman, Samsung Catalyst, Solasta Ventures, and Yield Capital | 5 |
9/14/2021 | Private Equity | |||||
11/11/2019 | Series B |
Date | 4/5/2023 | 1/27/2022 | 11/23/2021 | 9/14/2021 | 11/11/2019 |
---|---|---|---|---|---|
Round | PIPE | Private Equity | Series C - III | Private Equity | Series B |
Company | Yoshitsu | Poke Erchu | Rescale | ||
Amount | $50M | ||||
New? | Yes | Yes | Yes | ||
Co-Investors | Fort Ross Ventures, Gaingels, Gopher Asset Management, Hitachi Ventures, Initialized Capital, Jeff Bezos, Keen Venture Partners, M12, Nautilus Venture Partners, NVIDIA, Paul Graham, Peter Thiel, Prometheus Capital, Republic Labs, Richard Branson, Sam Altman, Samsung Catalyst, Solasta Ventures, and Yield Capital | ||||
Sources | 2 | 1 | 5 |
Prometheus Capital Portfolio Exits
3 Portfolio Exits
Prometheus Capital has 3 portfolio exits. Their latest portfolio exit was Purui Ophthalmology on July 05, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
7/5/2022 | IPO | Public | 1 | ||
Date | 7/5/2022 | ||
---|---|---|---|
Exit | IPO | ||
Companies | |||
Valuation | |||
Acquirer | Public | ||
Sources | 1 |
Prometheus Capital Fund History
1 Fund History
Prometheus Capital has 1 fund, including Opportune Capital Fund I.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
Opportune Capital Fund I | $4.31M | 1 |
Closing Date | |
---|---|
Fund | Opportune Capital Fund I |
Fund Type | |
Status | |
Amount | $4.31M |
Sources | 1 |